To this aim, we intravenously injected C57BL/6 mice with 1 × 105 re-programmed p185+ B-ALL cells engineered to express green fluorescent protein (GFP+) and monitored the mice for leukemia progression. This evidence concerns the gene EIF3A and leukemia.